Survey of diagnostic and typing capacity for Clostridium difficile infection in Europe, 2011 and 2014

Eurosurveillance

Volumn 21, Issue 29, 2016, Pages

  Van Dorp, S M ^a   Notermans, D W ^b   Alblas, J ^b   Gastmeier, P ^c   Mentula, S ^d   Nagy, E ^e   Spigaglia, P ^f   Ivanova, K ^g   Fitzpatrick, F ^h   Barbut, F ⁱ   Morris, T ^j   Wilcox, M H ^k   Kinross, P ^l   Suetens, C ^l   Kuijper, E J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY OF SZEGED   (Hungary)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^g NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^h HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

ⁱ National Reference Laboratory for Clostridium difficile   (France)

^j PUBLIC HEALTH WALES   (United Kingdom)

^k LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^l EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DEHYDROGENASE;

ACUTE DIARRHEA; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CYTOTOXICITY ASSAY; DISEASE SURVEILLANCE; ENZYME IMMUNOASSAY; EUROPE; HUMAN; MOLECULAR TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; PULSED FIELD GEL ELECTROPHORESIS; QUALITY CONTROL; QUESTIONNAIRE; RIBOTYPING; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; TERTIARY CARE CENTER; TRAINING; WORKSHOP; CLOSTRIDIUM INFECTIONS; DIARRHEA; GENETICS; HEALTH SURVEY; ISOLATION AND PURIFICATION; LABORATORY; LABORATORY INFORMATION SYSTEM; LABORATORY TEST; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES;

CLINICAL LABORATORY INFORMATION SYSTEMS; CLINICAL LABORATORY TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; EUROPE; HUMANS; LABORATORIES; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; RIBOTYPING; SURVEYS AND QUESTIONNAIRES;

EID: 85015132564     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.29.30292     Document Type: Article

References (34)

1. Kuijper EJ, Coignard B, Tüll P, ESCMID Study Group for Clostridium difficile, EU Member States, European Centre for Disease Prevention and Control. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect. 2006;12(Suppl 6):2-18. DOI: 10.1111/j.1469-0691.2006.01580.x. PMID: 16965399
2. European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. 2011- 2012. Stockholm: ECDC; 2013. Available from: http://www.ecdc.europa.eu/en/publications/Publications/healthcareassociated-infections-antimicrobial-use-PPS.pdf
3. Davies KA, Longshaw CM, Davis GL, Bouza E, Barbut F, Barna Z, et al. Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis. 2014;14(12):1208-19. DOI: 10.1016/S1473-3099(14)70991-0. PMID: 25455988
4. Alcalá L, Martín A, Marín M, Sánchez-Somolinos M, Catalán P, Peláez T, et al. The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem? Clin Microbiol Infect. 2012;18(7):E204-13. DOI: 10.1111/j.1469-0691.2012.03883.x. PMID: 22563775
5. Wilcox MH. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection.Clin Microbiol Infect. 2012;18(Suppl 6):13-20. DOI: 10.1111/1469-0691.12057. PMID: 23121550
6. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI).Clin Microbiol Infect. 2009;15(12):1053-66. DOI: 10.1111/j.1469-0691.2009.03098.x. PMID: 19929972
7. Planche T, Wilcox M. Reference assays for Clostridium difficile infection: one or two gold standards?J Clin Pathol. 2011;64(1):1-5. DOI: 10.1136/jcp.2010.080135. PMID: 21118850
8. Carroll KC. Tests for the diagnosis of Clostridium difficile infection: the next generation.Anaerobe. 2011;17(4):170-4. DOI: 10.1016/j.anaerobe.2011.01.002. PMID: 21376826
9. Shetty N, Wren MW, Coen PG. The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis. J Hosp Infect. 2011;77(1):1-6. DOI: 10.1016/j.jhin.2010.07.024. PMID: 21145132
10. O’Horo JC, Jones A, Sternke M, Harper C, Safdar N. Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis. Mayo Clin Proc. 2012 Jul;87(7):643-51. DOI: http://dx.doi.org/10.1016%2Fj.mayocp.2012.02.024. PMID: 22766084
11. Crobach MJ, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, et al. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016. Forthcoming.
12. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time.Scand J Gastroenterol. 1997;32(9):920-4. DOI: 10.3109/00365529709011203. PMID: 9299672
13. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection.Clin Infect Dis. 2008;46(s1) Suppl 1;S12-8. DOI: 10.1086/521863. PMID: 18177217
14. Barbut F, Surgers L, Eckert C, Visseaux B, Cuingnet M, Mesquita C, et al. Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management? Clin Microbiol Infect. 2014;20(2):136-44. DOI: 10.1111/1469-0691.12221. PMID: 23565919
15. Longtin Y, Trottier S, Brochu G, Paquet-Bolduc B, Garenc C, Loungnarath V, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56(1):67-73. DOI: 10.1093/cid/cis840. PMID: 23011147
16. Huber CA, Foster NF, Riley TV, Paterson DL. Challenges for standardization of Clostridium difficile typing methods. J Clin Microbiol 2013 Sep;51(9):2810-4. DOI: http://dx.doi.org/10.1128%2FJCM.00143-13. PMID: 23784128
17. Fawley WN, Knetsch CW, MacCannell DR, Harmanus C, Du T, Mulvey MR, et al. Development and validation of an internationally-standardized, high-resolution capillary gelbased electrophoresis PCR-ribotyping protocol for Clostridium difficile. PLoS One. 2015;10(2):e0118150. DOI: 10.1371/journal.pone.0118150. PMID: 25679978
18. Knetsch CW, Lawley TD, Hensgens MP, Corver J, Wilcox MW, Kuijper EJ. Current application and future perspectives of molecular typing methods to study Clostridium difficile infections. Euro Surveill. 2013;18(4):20381.PMID: 23369393
19. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, et al. Emergence and global spread of epidemic healthcareassociated Clostridium difficile. Nat Genet 2013 Jan;45(1):109-13. DOI: http://dx.doi.org/10.1038%2Fng.2478. PMID: 23222960
20. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet. 2011;377(9759):63-73. DOI: 10.1016/S0140-6736(10)61266-4. PMID: 21084111
21. European Clostridium difficile Surveillance Network (ECDISNet). Protocols and documents. Berlin: ECDIS-Net. [Accessed 16 May 2016]. Available from: http://ecdisnet.eu/index.php/home/protocol
22. Rossi E, Vita A, Baccetti S, Di Stefano M, Voller F, Zanobini A. Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe.Support Care Cancer. 2015;23(6):1795-806. DOI: 10.1007/s00520-014-2517-4. PMID: 25471177
23. Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis. 2013;13(11):936-45. DOI: 10.1016/S1473-3099(13)70200-7. PMID: 24007915
24. Bowker AH. A test for symmetry in contingency tables.J Am Stat Assoc. 1948;43(244):572-4. DOI: 10.1080/01621459.1948.10483284. PMID: 18123073
25. The Clostridium difficile subcommittee of the Scientific Advisory Committee of the Health Protection Surveillance Centre (HPSC) Surveillance, diagnosis and management of Clostridium difficile infection in Ireland. National Clinical Guideline No. 3. Dublin: Department of Health; 2014. Available from: http://health.gov.ie/wp-content/uploads/2015/01/National-Clinical-Guideline-No.-3-Clostridium-difficile.pdf
26. ADH/HCAI/ infectious disease. Updated guidance on the diagnosis and reporting of Clostridium difficile. London: Department of Health; 2012. Available from: https://www.gov.uk/government/publications/updated-guidance-on-thediagnosis-and-reporting-of-clostridium-difficile
27. Barbut F, Delmée M, Brazier JS, Petit JC, Poxton IR, Rupnik M, et al. A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect. 2003;9(10):989-96. DOI: 10.1046/j.1469-0691.2003.00683.x. PMID: 14616740
28. Gould CV, Edwards JR, Cohen J, Bamberg WM, Clark LA, Farley MM, et al. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis. 2013;57(9):1304-7. DOI: 10.1093/cid/cit492. PMID: 23899677
29. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, Birtles A, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotypingbased surveillance scheme in England. Clin Infect Dis. 2012;55(8):1056-63. DOI: 10.1093/cid/cis614. PMID: 22784871
30. Alcalá L, Marín M, Martín A, Sánchez-Somolinos M, Catalán P, Peláez MT, et al. Laboratory diagnosis of Clostridium difficile infection in Spain: a population-based survey. J Hosp Infect. 2011;79(1):13-7. DOI: 10.1016/j.jhin.2011.05.017. PMID: 21741114
31. Alcalá L, Reigadas E, Marín M, Martín A, Catalán P, Bouza E, Spanish Clostridium difficile Study Group. Impact of clinical awareness and diagnostic tests on the underdiagnosis of Clostridium difficile infection.Eur J Clin Microbiol Infect Dis. 2015;34(8):1515-25. DOI: 10.1007/s10096-015-2380-3. PMID: 25904126
32. Bouza E, Marín M, Peláez T, Alcalá L, Group for Clostridium difficile Infection of the Spanish Society for Chemotherapy. The situation and management of Clostridium difficile infection in Spain: an opinion document.Rev Esp Quimioter. 2013;26(3):261-86.PMID: 24080894
33. Pituch H, Obuch-Woszczatyński P, Lachowicz D, Wultańska D, Karpiński P, Młynarczyk G, et al. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013. Euro Surveill. 2015;20(38):30025. DOI: 10.2807/1560-7917.ES.2015.20.38.30025. PMID: 26536049
34. European Centre for Disease Prevention and Control (ECDC). Minutes of the 39th meeting of the Advisory Forum, Stockholm, 24-25 September 2014. Stockholm: ECDC; 2014. Available from: http://ecdc.europa.eu/en/aboutus/governance/af/AF%20%20Meeting%20Minutes/Advisory-Forum-minutesmeeting-39.pdf